These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1404131)

  • 61. Doxycycline inhibits type X collagen synthesis in avian hypertrophic chondrocyte cultures.
    Davies SR; Cole AA; Schmid TM
    J Biol Chem; 1996 Oct; 271(42):25966-70. PubMed ID: 8824232
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of the efficacy of various concentrations and combinations of serum, ethylenediaminetetraacetic acid, tetracycline, doxycycline, minocycline, and N-acetylcysteine for inhibition of collagenase activity in an in vitro corneal degradation model.
    Kimmitt BA; Moore GE; Stiles J
    Am J Vet Res; 2018 May; 79(5):555-561. PubMed ID: 29688786
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Introduction and background.
    Golub LM
    Pharmacol Res; 2011 Feb; 63(2):99-101. PubMed ID: 20937387
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs.
    Golub LM; Ramamurthy NS; McNamara TF; Greenwald RA; Rifkin BR
    Crit Rev Oral Biol Med; 1991; 2(3):297-321. PubMed ID: 1654139
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intra-articular injection of stromelysin into rabbit knees as a model to evaluate matrix metalloprotease inhibitors.
    Goldberg RL; Parker D; MacPherson L; Ganu V; Melton R; Hu SI; Blancuzzi V; Wilson D; Doughty J; Spirito S
    Inflamm Res; 1995 Aug; 44 Suppl 2():S115-6. PubMed ID: 8548355
    [No Abstract]   [Full Text] [Related]  

  • 66. Localization and characterization of matrix metalloproteinase-9 in experimental rat adjuvant arthritis.
    Stein-Picarella M; Ahrens D; Mase C; Golden H; Niedbala MJ
    Ann N Y Acad Sci; 1994 Sep; 732():484-5. PubMed ID: 7978846
    [No Abstract]   [Full Text] [Related]  

  • 67. The road forward: the scientific basis for tetracycline treatment of arthritic disorders.
    Greenwald RA
    Pharmacol Res; 2011 Dec; 64(6):610-3. PubMed ID: 21723947
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Application of chemically modified tetracyclines (CMTs) in experimental models of cancer and arthritis.
    Seftor EA; Seftor RE; Nieva DR; Hendrix MJ
    Adv Dent Res; 1998 Nov; 12(2):103-10. PubMed ID: 9972131
    [No Abstract]   [Full Text] [Related]  

  • 69. Effect of tetracyclines on collagenase activity in patients with recurrent aphthous ulcers.
    Häyrinen-Immonen R; Sorsa T; Pettilä J; Konttinen YT; Teronen O; Malmström M
    J Oral Pathol Med; 1994 Jul; 23(6):269-72. PubMed ID: 7932246
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative effects of benoxaprofen and other anti-inflammatory drugs on bone damage in the adjuvant arthritic rat.
    Benslay DN; Nickander R
    Agents Actions; 1982 Jul; 12(3):313-9. PubMed ID: 7136958
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Doxycycline and other tetracyclines in the treatment of bone metastasis.
    Saikali Z; Singh G
    Anticancer Drugs; 2003 Nov; 14(10):773-8. PubMed ID: 14597870
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Suppression of human neutrophil functions by tetracyclines.
    Gabler WL; Creamer HR
    J Periodontal Res; 1991 Jan; 26(1):52-8. PubMed ID: 1847418
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action.
    Griffin MO; Ceballos G; Villarreal FJ
    Pharmacol Res; 2011 Feb; 63(2):102-7. PubMed ID: 20951211
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tetracycline derivatives inhibit cartilage degradation in cultured embryonic chick tibiae.
    Orth MW; Chlebek KA; Cole AA; Schmid TM
    Res Vet Sci; 1997; 63(1):11-4. PubMed ID: 9368950
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Suppression of experimental aneurysmal degeneration with chemically modified tetracycline derivatives.
    Petrinec D; Holmes DR; Liao S; Golub LM; Thompson RW
    Ann N Y Acad Sci; 1996 Nov; 800():263-5. PubMed ID: 8959009
    [No Abstract]   [Full Text] [Related]  

  • 76. Potential of tetracyclines to modify cartilage breakdown in osteoarthritis.
    Ryan ME; Greenwald RA; Golub LM
    Curr Opin Rheumatol; 1996 May; 8(3):238-47. PubMed ID: 8796985
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tetracyclines Inhibit Tissue Collagenases: Effects of Ingested Low-Dose and Local Delivery Systems.
    Golub LM; Goodson JM; Lee HM; Vidal AM; McNamara TF; Ramamurthy NS
    J Periodontol; 1985 Nov; 56 Suppl 11S():93-97. PubMed ID: 29538954
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MMP inhibition by chemically modified tetracycline-3 (CMT-3) in equine pulmonary epithelial lining fluid.
    Maisi P; Kiili M; Raulo SM; Pirilä E; Sorsa T
    Ann N Y Acad Sci; 1999 Jun; 878():675-7. PubMed ID: 10415805
    [No Abstract]   [Full Text] [Related]  

  • 79. The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.
    Paemen L; Martens E; Norga K; Masure S; Roets E; Hoogmartens J; Opdenakker G
    Biochem Pharmacol; 1996 Jul; 52(1):105-11. PubMed ID: 8678893
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Inhibition of bacterial and mammalian collagenolytic activities by tetracyclines].
    Maehara R; Hinode D; Terai H; Sato M; Nakamura R; Matsuda N; Tanaka T; Sugihara K
    Nihon Shishubyo Gakkai Kaishi; 1988 Mar; 30(1):182-90. PubMed ID: 3254384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.